Generic Drug Maker

'Generic Drug Maker' - 44 News Result(s)

  • Merck COVID-19 Pill Has Vital Indian Link, Maker Sees Stock Price Jump
    India News | Reuters | Tuesday October 12, 2021
    India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.
    www.ndtv.com
  • Hyderabad-Based Hetero Prices Generic COVID-19 Drug At Rs 5,400 Per Vial
    India News | Reuters | Wednesday June 24, 2020
    Hyderabad-based Hetero Labs Ltd has priced its generic version of remdesivir, Gilead's experimental COVID-19 drug, at Rs 5,400 ($71) per 100-milligram vial, the drug maker said on Wednesday, as it prepares to ship them to hospitals in the country.
    www.ndtv.com
  • Aurobindo Pharma Buys Parts Of Sandoz US From Novartis For $900 Million
    Business | Thomson Reuters | Thursday September 6, 2018
    Novartis AG said on Thursday it would sell the dermatology and generic US oral solids portfolios of Sandoz US to Aurobindo Pharma Ltd for $900 million, as the Swiss drug maker looks to focus on higher growth areas. The deal also includes about 300 products and additional development projects of Sandoz and an additional $100 million in performance...
    www.ndtv.com/business
  • Lupin Looks To Clean Up Its Act As FDA Steps Up Inspections
    India News | Thomson Reuters | Sunday July 9, 2017
    Often dubbed "the pharmacy of the world", India is home to the most FDA-approved plants outside of the United States
    www.ndtv.com
  • Pfizer Abandons Plan To Split Into Two
    Business | Thomson Reuters | Monday September 26, 2016
    US drug maker Pfizer Inc said on Monday it had decided not to separate into two publicly traded companies by separating its low-growth generics from its patent-protected branded medicines.
    www.ndtv.com/business
  • AstraZeneca Q2 Earnings Hit By Waning Cholesterol Drug Sales
    Business | Thomson Reuters | Thursday July 28, 2016
    Generic competition to cholesterol buster Crestor in the US market pushed second quarter earnings down by nearly a third at drug maker AstraZeneca, which is now banking on new cancer medicines to revive its fortunes.
    www.ndtv.com/business
  • Sensex Ends Over 100 Points Higher On Buying In Pharma Shares
    Business | Agencies | Wednesday July 20, 2016
    Indian shares rose on Wednesday on the back of broad-based buying while pharma stocks outperformed as drug makers such as Glenmark Pharmaceuticals and Aurobindo Pharma gained after getting approvals for generic versions of a blockbuster cholesterol drug in the U.S.
    www.ndtv.com/business
  • Sun Pharma Enters Dermatology Segment To Expand Retail Offering
    Business | Thomson Reuters | Wednesday June 8, 2016
    The world's fifth biggest generic drug maker launched a new dermatology product - Suncros - a sunscreen brand which was earlier available only as a branded prescription product.
    www.ndtv.com/business
  • Sun Pharma Gets US Subpoena Over Generic Drugs Pricing
    Business | Thomson Reuters | Sunday May 29, 2016
    The US Department of Justice (DoJ) has subpoenaed India's largest drug maker Sun Pharmaceutical Industries Ltd seeking information about the pricing and marketing of the generic drugs it sells in the United States, the company said on Saturday.
    www.ndtv.com/business
  • Two Indian Generics Makers End Battle to Copy Drugs Amid Patent Debate
    Business | Thomson Reuters | Tuesday April 12, 2016
    Two Indian drug makers said they had given up a battle to copy drugs developed by Bristol Myers Squibb and AstraZeneca, blaming a lack of government support for cheap generics and pressure from Big Pharma.
    www.ndtv.com/business
  • UK Competition Authorities Fine GlaxoSmithKline $54.5 Million
    World News | Associated Press | Friday February 12, 2016
    Britain's competition authority has fined drug maker GlaxoSmithKline plc 37.6 million pounds ($54.5 million) for stalling the potential entry of generic competitors of an anti-depressant drug Seroxat into the marketplace.
    www.ndtv.com
  • US Court Imposes Temporary Sales Ban on Dr Reddy's Generic Heartburn Drug
    Business | Thomson Reuters | Tuesday November 10, 2015
    Dr Reddy's Laboratories Ltd, India's second largest drug maker by sales, said on Tuesday it had been temporarily barred by a US court from selling its generic form of blockbuster heartburn drug Nexium in the United States.
    www.ndtv.com/business
  • India's 100 Richest Includes Only 4 Women
    India News | Press Trust of India | Thursday September 24, 2015
    Four women feature in this year's Forbes list of 100 richest Indians including O P Jindal group Chairperson Savitri Jindal and generic drugs maker USV Pharma Chairperson Leena Tewari.
    www.ndtv.com
  • Dr Reddy's, BioMarin Settle Patent Litigation on Kuvan Tablets
    Business | Press Trust of India | Monday September 21, 2015
    According to a statement issued by BioMarin, the US drugmaker said it will grant Dr Reddy's a non-exclusive licence to its patents on Kuvan (sapropterin dihydrochloride) allowing the Indian drug maker to market a generic version of Kuvan 100mg tablets in the US at a later stage, which is expected to be more than five years from now.
    www.ndtv.com/business
  • Dr Reddy's Lab to Enter Japanese Market Through a Partner
    Business | Tuesday May 12, 2015
    The Indian drug maker and Fujifilm Corporation of Japan had earlier entered into an MoU for an exclusive partnership in the generic drugs business for the Japanese market and to establish a joint venture in the island nation.
    www.ndtv.com/business

'Generic Drug Maker' - 1 Video Result(s)

'Generic Drug Maker' - 44 News Result(s)

  • Merck COVID-19 Pill Has Vital Indian Link, Maker Sees Stock Price Jump
    India News | Reuters | Tuesday October 12, 2021
    India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.
    www.ndtv.com
  • Hyderabad-Based Hetero Prices Generic COVID-19 Drug At Rs 5,400 Per Vial
    India News | Reuters | Wednesday June 24, 2020
    Hyderabad-based Hetero Labs Ltd has priced its generic version of remdesivir, Gilead's experimental COVID-19 drug, at Rs 5,400 ($71) per 100-milligram vial, the drug maker said on Wednesday, as it prepares to ship them to hospitals in the country.
    www.ndtv.com
  • Aurobindo Pharma Buys Parts Of Sandoz US From Novartis For $900 Million
    Business | Thomson Reuters | Thursday September 6, 2018
    Novartis AG said on Thursday it would sell the dermatology and generic US oral solids portfolios of Sandoz US to Aurobindo Pharma Ltd for $900 million, as the Swiss drug maker looks to focus on higher growth areas. The deal also includes about 300 products and additional development projects of Sandoz and an additional $100 million in performance...
    www.ndtv.com/business
  • Lupin Looks To Clean Up Its Act As FDA Steps Up Inspections
    India News | Thomson Reuters | Sunday July 9, 2017
    Often dubbed "the pharmacy of the world", India is home to the most FDA-approved plants outside of the United States
    www.ndtv.com
  • Pfizer Abandons Plan To Split Into Two
    Business | Thomson Reuters | Monday September 26, 2016
    US drug maker Pfizer Inc said on Monday it had decided not to separate into two publicly traded companies by separating its low-growth generics from its patent-protected branded medicines.
    www.ndtv.com/business
  • AstraZeneca Q2 Earnings Hit By Waning Cholesterol Drug Sales
    Business | Thomson Reuters | Thursday July 28, 2016
    Generic competition to cholesterol buster Crestor in the US market pushed second quarter earnings down by nearly a third at drug maker AstraZeneca, which is now banking on new cancer medicines to revive its fortunes.
    www.ndtv.com/business
  • Sensex Ends Over 100 Points Higher On Buying In Pharma Shares
    Business | Agencies | Wednesday July 20, 2016
    Indian shares rose on Wednesday on the back of broad-based buying while pharma stocks outperformed as drug makers such as Glenmark Pharmaceuticals and Aurobindo Pharma gained after getting approvals for generic versions of a blockbuster cholesterol drug in the U.S.
    www.ndtv.com/business
  • Sun Pharma Enters Dermatology Segment To Expand Retail Offering
    Business | Thomson Reuters | Wednesday June 8, 2016
    The world's fifth biggest generic drug maker launched a new dermatology product - Suncros - a sunscreen brand which was earlier available only as a branded prescription product.
    www.ndtv.com/business
  • Sun Pharma Gets US Subpoena Over Generic Drugs Pricing
    Business | Thomson Reuters | Sunday May 29, 2016
    The US Department of Justice (DoJ) has subpoenaed India's largest drug maker Sun Pharmaceutical Industries Ltd seeking information about the pricing and marketing of the generic drugs it sells in the United States, the company said on Saturday.
    www.ndtv.com/business
  • Two Indian Generics Makers End Battle to Copy Drugs Amid Patent Debate
    Business | Thomson Reuters | Tuesday April 12, 2016
    Two Indian drug makers said they had given up a battle to copy drugs developed by Bristol Myers Squibb and AstraZeneca, blaming a lack of government support for cheap generics and pressure from Big Pharma.
    www.ndtv.com/business
  • UK Competition Authorities Fine GlaxoSmithKline $54.5 Million
    World News | Associated Press | Friday February 12, 2016
    Britain's competition authority has fined drug maker GlaxoSmithKline plc 37.6 million pounds ($54.5 million) for stalling the potential entry of generic competitors of an anti-depressant drug Seroxat into the marketplace.
    www.ndtv.com
  • US Court Imposes Temporary Sales Ban on Dr Reddy's Generic Heartburn Drug
    Business | Thomson Reuters | Tuesday November 10, 2015
    Dr Reddy's Laboratories Ltd, India's second largest drug maker by sales, said on Tuesday it had been temporarily barred by a US court from selling its generic form of blockbuster heartburn drug Nexium in the United States.
    www.ndtv.com/business
  • India's 100 Richest Includes Only 4 Women
    India News | Press Trust of India | Thursday September 24, 2015
    Four women feature in this year's Forbes list of 100 richest Indians including O P Jindal group Chairperson Savitri Jindal and generic drugs maker USV Pharma Chairperson Leena Tewari.
    www.ndtv.com
  • Dr Reddy's, BioMarin Settle Patent Litigation on Kuvan Tablets
    Business | Press Trust of India | Monday September 21, 2015
    According to a statement issued by BioMarin, the US drugmaker said it will grant Dr Reddy's a non-exclusive licence to its patents on Kuvan (sapropterin dihydrochloride) allowing the Indian drug maker to market a generic version of Kuvan 100mg tablets in the US at a later stage, which is expected to be more than five years from now.
    www.ndtv.com/business
  • Dr Reddy's Lab to Enter Japanese Market Through a Partner
    Business | Tuesday May 12, 2015
    The Indian drug maker and Fujifilm Corporation of Japan had earlier entered into an MoU for an exclusive partnership in the generic drugs business for the Japanese market and to establish a joint venture in the island nation.
    www.ndtv.com/business

'Generic Drug Maker' - 1 Video Result(s)

Your search did not match any documents
A few suggestions
  • Make sure all words are spelled correctly
  • Try different keywords
  • Try more general keywords
Check the NDTV Archives:https://archives.ndtv.com
Listen to the latest songs, only on JioSaavn.com